(May 16, 2014) Breastfeeding, tubal ligation – also known as having one’s “tubes tied” – and oral contraceptives may lower the risk of ovarian cancer for some women with BRCA … Continued
(May 6, 2014) Tumors use numerous mechanisms to escape detection and killing by the immune system. Results from OCRF-funded research, reported May 4, 2014 in the prestigious journal Nature Medicine, … Continued
(April 30, 2014) A positive pretreatment imaging test more than doubled the likelihood of disease control in platinum-resistant advanced ovarian cancer treated with the folate receptor-targeted drug vintafolide (trade name … Continued
With two marquee scientific conferences, the Society for Gynecologic Oncology (SGO) and the American Association for Cancer Research (AACR), occurring back-to-back, the past few weeks have seen an explosion in … Continued
(April 15, 2014) Prolonged (>35 days), infrequent, or anovulatory menstrual cycles was associated with as much as a two-fold increase in ovarian cancer and more than a three-fold increase in … Continued
(April 8, 2014) A team of researchers have found that vigorous physical activity prior to ovarian cancer diagnosis was associated with a lower risk of ovarian cancer mortality. The findings … Continued
(April 7, 2014) A group of OCRF-funded researchers at Baylor College of Medicine have found a “fusion gene” that is present in 20% of high grade serous ovarian cancer patients. … Continued
Last week marked the 20th year anniversary of the discovery of the BRCA1 gene by Mary-Claire King, Ph.D., an American geneticist. Dr. King, who was interviewed last week by NPR, … Continued
Compiled by Robin Cohen, President-Elect, Ovarian Cancer National Alliance As in years past, a wealth of clinical research into ovarian cancer was presented at the 2014 Society for Gynecologic Oncology … Continued
(April 1, 2014) Ovarian Cancer Research Fund is now accepting Letters of Intent for its three research grant programs. Letters of Intent must be submitted by May 6, 2014 at … Continued
A rare type of ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type (or SCCOHT) can affect women and girls as young as 14 months old. This week, … Continued
Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in … Continued
Get email updates about research news, action alerts, and ways to join the fight.
